Non-Invasive Prenatal Testing Market: By Product Type (Consumables and Reagents, Instruments), By End User (Public Labs, Private Labs), and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Non-Invasive Prenatal Testing Market Size was valued at USD 3.6 billion in 2022 and is poised to grow at a CAGR of 9.6% from 2023 to 2029. Noninvasive prenatal testing is a new type of genetic testing that is used to screen birth defects and inherited diseases. This test is also known as the cell-free DNA screening. The procedures include both non-invasive techniques and invasive techniques. In non-invasive techniques, serum screening and ultrasonography are included. Whereas, in invasive techniques amniocentesis and chorionic villus sampling are included. Most of the healthcare professionals prefer the non-invasive techniques over invasive, as the invasive techniques have higher risk quotient, also sometimes leads to fetal loss. Noninvasive prenatal testing are the innovative testing procedures that uses cell-free circulating fetal DNA in the maternal serum to screen for more common fetal aneuploidies, such as trisomy 21, trisomy 18 (Edward syndrome), trisomy 13 (Patau syndrome), and monosomy X (Turner syndrome). Increasing prevalence of these genetic disorders are likely to drive the market for non-invasive prenatal testing over the forecast period. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes regulatory scenario and competition analysis with vividly illustrated the competition dashboard to assess the market competition. The major market participants are adopting the strategies such as mergers and acquisitions to position themselves as strong players.

Non-Invasive Prenatal Testing Market Key Developments:
In February 2018, BD (Becton, Dickinson and Company) announced the commercial availability of the CE-IVD marked PAXgene Blood ccfDNA tube within the European Economic Area and Switzerland (Western Europe).

Non Invasive Prenatal Testing Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

9.8%

Largest Market

North America

Fastest Growing Market

Europe
Noninvasive Prenatal Testing Market Dynamics

The rising awareness among parents, adoption toward IVF procedures is driving the market. In birth outcomes such as birth defects, newborn weight, and multiple births, maternal age plays a major role. The average age at which women are giving first birth has been increasing. As per Centre for Disease Control and Prevention (CDC) report, the mean age of a women at first birth was 25.8 years in 2012, and it has increased to 26 years in 2013, in the U.S. In addition to that, according to the World Health Organization (WHO), about 3,000 to 5,000 children are born with chromosome disorder, approximately 60%-80% of the children with Down syndrome have hearing deficit, and 40%-45% have congenital heart disease. The rise in the prevalence of these genetic disorders is likely to drive the market for non-invasive prenatal testing market.

Non Invasive Prenatal Testing Market Segmentation

By Product Type
  • Instruments
    • Microarrays
    • Ultrasound Devices
    • NGS Systems
    • PCR Instruments
    • Other Instruments
  • Consumables
    • Assay Kits &Reagents
    • Disposables
By End User
  • Hospitals
  • Maternity Clinics
  • Diagnostic Centers
By Geography
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
1. Executive Summary
2. Global Non-Invasive Prenatal Testing Market Introduction
2.1. Global Non-Invasive Prenatal Testing Market Taxonomy
2.2. Global Non-Invasive Prenatal Testing Market Definitions
2.2.1. By Product Type
2.2.2. By End User
2.2.3. By Region
3. Global Non-Invasive Prenatal Testing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Non-Invasive Prenatal Testing Market Dynamic Factors - Impact Analysis
3.6. Global Non-Invasive Prenatal Testing Market – Competition Landscape
4. Global Non-Invasive Prenatal Testing Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Non-Invasive Prenatal Testing Market, By Product Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) 
5.1. Consumables and Reagents
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Instruments
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
6. Global Non-Invasive Prenatal Testing Market, By End User, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) 
6.1. Public Labs
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Private Labs
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
7. Global Non-Invasive Prenatal Testing Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) 
7.1. North America
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Non-Invasive Prenatal Testing Market - Opportunity Analysis Index, By Product Type, End User, and Region, 2023 - 2029
8. North America Non-Invasive Prenatal Testing Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) 
8.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.1.1. Consumables and Reagents
8.1.2. Instruments
8.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.2.1. Public Labs
8.2.2. Private Labs
8.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.3.1. USA
8.3.2. Canada
8.4. North America Non-Invasive Prenatal Testing Market - Opportunity Analysis Index, By Product Type, End User, and Country, 2023 - 2029
8.5. North America Non-Invasive Prenatal Testing Market Dynamics – Trends
9. Europe Non-Invasive Prenatal Testing Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) 
9.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Consumables and Reagents
9.1.2. Instruments
9.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Public Labs
9.2.2. Private Labs
9.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Rest of Europe
9.4. Europe Non-Invasive Prenatal Testing Market - Opportunity Analysis Index, By Product Type, End User, and Country, 2023 - 2029
9.5. Europe Non-Invasive Prenatal Testing Market Dynamics – Trends
10. Asia-Pacific Non-Invasive Prenatal Testing Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) 
10.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Consumables and Reagents
10.1.2. Instruments
10.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Public Labs
10.2.2. Private Labs
10.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. ASEAN
10.3.5. Australia & New Zealand
10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Non-Invasive Prenatal Testing Market - Opportunity Analysis Index, By Product Type, End User, and Country, 2023 - 2029
10.5. Asia-Pacific Non-Invasive Prenatal Testing Market Dynamics – Trends
11. Latin America Non-Invasive Prenatal Testing Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) 
11.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Consumables and Reagents
11.1.2. Instruments
11.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Public Labs
11.2.2. Private Labs
11.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Argentina
11.3.4. Rest of Latin America
11.4. Latin America Non-Invasive Prenatal Testing Market - Opportunity Analysis Index, By Product Type, End User, and Country, 2023 - 2029
11.5. Latin America Non-Invasive Prenatal Testing Market Dynamics – Trends
12. Middle East and Africa Non-Invasive Prenatal Testing Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) 
12.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Consumables and Reagents
12.1.2. Instruments
12.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Public Labs
12.2.2. Private Labs
12.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Gulf Cooperation Council (GCC) Countries
12.3.2. Israel
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Non-Invasive Prenatal Testing Market - Opportunity Analysis Index, By Product Type, End User, and Country, 2023 - 2029
12.5. MEA Non-Invasive Prenatal Testing Market Dynamics – Trends
13. Competition Landscape 
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Product Type Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. F. Hoffmann-La Roche Ltd.
13.2.2. PerkinElmer Inc.
13.2.3. Natera, Inc.
13.2.4. BGI
13.2.5. Laboratory Corp. of America Holdings
13.2.6. Agilent Technologies
13.2.7. Centogene N.V.
13.2.8. Illumina, Inc.
13.2.9. Qiagen N.V.
13.2.10. Quest Diagnostics
14. Research Methodology
15. Key Assumptions and Acronyms
  • PerkinElmer, Inc. (U.S.)
  • QIAGEN N.V. (Germany)
  • Becton, Dickinson and Company (U.S)
  • Agilent Technologies, Inc. (U.S.)
  • Beijing Genomics Institute (China)
  • GE Healthcare (U.S.)
  • Koninklijke Philips N.V. (Netherlands)
  • Illumina, Inc. (U.S.)
  • Thermo Fisher Scientific, Inc. (U.S.)
  • Hoffmann-La Roche Ltd. (Switzerland)
  • Pacific Biosciences of California, Inc. (U.S.)

Adjacent Markets